Serum calprotectin correlates with risk and disease severity in psoriasis patients and the decrease of calprotectin predicts better response to tumor necrosis factor inhibitors
Type
Retraction
Notice date
5/1/2021 0:00
Journal
European Review for Medical and Pharmacological Sciences